Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loaded db/db Mice.

Published on Jun 1, 2021in Hypertension7.713
· DOI :10.1161/HYPERTENSIONAHA.121.17263
Daigoro Hirohama11
Estimated H-index: 11
(UTokyo: University of Tokyo),
Mitsuhiro Nishimoto9
Estimated H-index: 9
(UTokyo: University of Tokyo)
+ 6 AuthorsToshiro Fujita121
Estimated H-index: 121
(UTokyo: University of Tokyo)
The progression of diabetic kidney disease (DKD), a leading cause of end-stage kidney disease, involves mineralocorticoid receptor (MR) activation. We previously identified crosstalk between the small guanosine triphosphatase (GTPase) RAS-related C3 botulinus toxin substrate 1 (Rac1) and MR, but the role of Rac1-MR pathway activation in the progression of DKD is not clear. We performed uninephrectomy on type 2 diabetic mouse models, db/db (UNx-high salt [HS] db/db), and their lean control, db/m (UNx-HS db/m), at 4-week postpartum, and fed them a high-salt diet for 10 weeks. To evaluate the involvement of the Rac1-MR pathway in the DKD progression, we investigated the effects of the nonsteroidal MR antagonist, finerenone, and the Rac1 inhibitor, NSC23766, on blood pressure and glomerular injury in UNx-HS db/db mice. UNx-HS db/db mice with hyperaldosteronism showed hypertension and hypokalemia with increased cleaved α-epithelial sodium channel expressions and massive albuminuria, accompanied by glomerular injury with nodular lesions, which is a characteristic finding in human diabetic nephropathy. Expressions of active Rac1 and serum-and glucocorticoid-induced protein kinase 1 (Sgk1), a downstream molecule of MR signaling, in the renal cortex and isolated glomeruli, significantly elevated in UNx-HS db/db mice, associated with intense staining of active Rac1 in glomerular podocytes, but both hypertension and renal injury were ameliorated by NSC23766 and finerenone, associated with Sgk1 inhibition, suggesting that Rac1-MR activation contributes to hypertension and podocyte injury. In conclusion, salt-induced activation of Rac1-MR pathway in distal tubules and glomeruli is involved in DKD progression through hypertension and glomerular injury, respectively. This finding highlights MR antagonism along with Rac1 inhibition as a novel strategy for DKD treatment.
📖 Papers frequently viewed together
29 Citations
7 Authors (吕林莉, ..., 胡泽波)
#1Luciana C Veiras (Cedars-Sinai Medical Center)H-Index: 2
#2Justin Z.Y. Shen (Cedars-Sinai Medical Center)H-Index: 1
Last. Jorge F. Giani (Cedars-Sinai Medical Center)H-Index: 25
view all 11 authors...
BACKGROUND Hypertension is considered a major risk factor for the progression of diabetic kidney disease. Type 2 diabetes is associated with increased renal sodium reabsorption and salt-sensitive hypertension. Clinical studies show that men have higher risk than premenopausal women for the development of diabetic kidney disease. However, the renal mechanisms that predispose to salt sensitivity during diabetes and whether sexual dimorphism is associated with these mechanisms remains unknown. METH...
#1Stephanie M. Mutchler (University of Pittsburgh)H-Index: 10
#2Annet Kirabo (Vandy: Vanderbilt University)H-Index: 18
Last. Thomas R. Kleyman (University of Pittsburgh)H-Index: 60
view all 3 authors...
The development of high blood pressure is influenced by genetic and environmental factors, with high salt intake being a known environmental contributor. Humans display a spectrum of sodium-sensitivity, with some individuals displaying a significant blood pressure rise in response to increased sodium intake while others experience almost no change. These differences are, in part, attributable to genetic variation in pathways involved in sodium handling and excretion. ENaC (epithelial sodium chan...
#1Gerasimos Filippatos (UoA: National and Kapodistrian University of Athens)H-Index: 129
#2Stefan D. Anker (Charité)H-Index: 173
Last. George Bakris (U of C: University of Chicago)H-Index: 3
view all 11 authors...
Background: The FIDELIO-DKD trial (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) evaluated the effect of the nonsteroidal, selective mineralocorticoid re...
3 CitationsSource
#1George L. BakrisH-Index: 135
#2Rajiv Agarwal (Mario Negri Institute for Pharmacological Research)H-Index: 1
view all 12 authors...
Abstract Background Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and ty...
51 CitationsSource
#1Ashley L. Pitzer (VUMC: Vanderbilt University Medical Center)H-Index: 3
#2Justin P Van Beusecum (VUMC: Vanderbilt University Medical Center)H-Index: 7
Last. Annet Kirabo (VUMC: Vanderbilt University Medical Center)H-Index: 18
view all 4 authors...
The main goal of this article is to discuss the role of the epithelial sodium channel (ENaC) in extracellular fluid and blood pressure regulation. Besides its role in sodium handling in the kidney, recent studies have found that ENaC expressed in other cells including immune cells can influence blood pressure via extra-renal mechanisms. Dendritic cells (DCs) are activated and contribute to salt-sensitive hypertension in an ENaC-dependent manner. We discuss recent studies on how ENaC is regulated...
4 CitationsSource
#1Daigoro Hirohama (UTokyo: University of Tokyo)H-Index: 11
#2Wakako Kawarazaki (UTokyo: University of Tokyo)H-Index: 11
Last. Toshiro Fujita (UTokyo: University of Tokyo)H-Index: 121
view all 7 authors...
Renal inflammation is known to be involved in salt-induced renal damage, leading to end-stage renal disease. This study aims to evaluate the role of inflammation in anti-inflammatory and renoprotective effects of beraprost sodium (BPS), a prostaglandin I2 (PGI2) analog, in Dahl salt-sensitive (DS) rats. Five-week-old male DS rats were fed a normal-salt diet (0.5% NaCl), a high-salt diet (8% NaCl), or a high-salt diet plus BPS treatment for 3 weeks. BPS treatment could inhibit marked proteinuria ...
#1Volker Vallon (UCSD: University of California, San Diego)H-Index: 80
#2Scott C. Thomson (UCSD: University of California, San Diego)H-Index: 47
Kidney size and glomerular filtration rate (GFR) often increase with the onset of diabetes, and elevated GFR is a risk factor for the development of diabetic kidney disease. Hyperfiltration mainly occurs in response to signals passed from the tubule to the glomerulus: high levels of glucose in the glomerular filtrate drive increased reabsorption of glucose and sodium by the sodium–glucose cotransporters SGLT2 and SGLT1 in the proximal tubule. Passive reabsorption of chloride and water also incre...
37 CitationsSource
#1Parker C. Wilson (WashU: Washington University in St. Louis)H-Index: 8
#2Haojia Wu (WashU: Washington University in St. Louis)H-Index: 19
Last. Benjamin D. Humphreys (WashU: Washington University in St. Louis)H-Index: 66
view all 9 authors...
Diabetic nephropathy is characterized by damage to both the glomerulus and tubulointerstitium, but relatively little is known about accompanying cell-specific changes in gene expression. We performed unbiased single-nucleus RNA sequencing (snRNA-seq) on cryopreserved human diabetic kidney samples to generate 23,980 single-nucleus transcriptomes from 3 control and 3 early diabetic nephropathy samples. All major cell types of the kidney were represented in the final dataset. Side-by-side compariso...
68 CitationsSource
#1Justin P Van Beusecum (VUMC: Vanderbilt University Medical Center)H-Index: 7
#2Natalia R. Barbaro (VUMC: Vanderbilt University Medical Center)H-Index: 13
Last. Annet Kirabo (Vandy: Vanderbilt University)H-Index: 18
view all 10 authors...
Salt-sensing mechanisms in hypertension involving the kidney, vasculature, and central nervous system have been well studied; however, recent studies suggest that immune cells can sense sodium (Na+...
32 CitationsSource
#1Kengo Azushima (YCU: Yokohama City University)H-Index: 14
#2Susan B. Gurley (Duke University)H-Index: 30
Last. Thomas M. Coffman (NUS: National University of Singapore)H-Index: 86
view all 3 authors...
Animal models that faithfully recapitulate human diabetic nephropathy (DN) are needed to study disease pathogenesis, identify drug targets and test new therapies. Here, the authors review progress in developing mouse models of DN, the limitations of current models, and opportunities for future development.
46 CitationsSource
Cited By0